You are here

Nova Mentis Life Science Corp.

Nova Mentis Life Science Corp.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
NOVA
CSE Index: 
Currency: 

Nova Mentis Life Science Corp. is a Canadian-based biotechnology company and global leader in psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders. Their mission is to diagnose and treat debilitating chronic conditions that have unmet medical needs, such as autism spectrum disorder and fragile X syndrome.

You are here

Nova Mentis Life Science Corp. (NOVA)

SEDAR Information

Company Info

Address
700-838 W Hastings Street
Vancouver, BC V6C 0A6
Canada
Phone
778-819-0244
Email
info@novamentis.ca
Website
http://www.novamentis.ca
Listing date
Tuesday, February 10, 2015
Transfer Agent
Olympia Trust Company
Investor Relations
William Rascan
Email
info@novamentis.ca
Auditor
Kreston GTA LLP

Capitalization

Issued & Outstanding: 
148318660
Reserved for Issuance: 
8329866

Company Officers

Will Rascan, Chief Executive Officer
Kelly Pladson, Corporate Secretary
Rebecca Hudson, Chief Financial Officer
Derek Ivany, Executive Chair

Bulletins

08/08/2024

2024-0809 - WITHDRAWN - Symbol Change - Inactive Designation - Nova Mentis Life Science Corp. (NOVA)

le 8 août/August 2024

 

Bulletin 2024-0809 - Symbol Change - Inactive Designation - Nova Mentis Life Science Corp. (NOVA) has been withdrawn.

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com